Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_assertion type Assertion NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_head.
- NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_assertion description "[Some of them, including Tumor Necrosis Factor-alpha, Interferon-gamma-inducible Protein-10, Monocyte Chemotactic Protein-1 and Interleukin-8, are increased in AD and in Mild Cognitive Impairment (MCI), considered the prodromal stage of AD, suggesting that these modifications occur very early during the development of the disease, possibly explaining the failure of trials with anti-inflammatory agents in patients with severe AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_provenance.
- NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_assertion evidence source_evidence_literature NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_provenance.
- NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_assertion SIO_000772 20021370 NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_provenance.
- NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_assertion wasDerivedFrom befree-20150227 NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_provenance.
- NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_assertion wasGeneratedBy ECO_0000203 NP502294.RASfU2D_vONw4gjqvQfEeOuJBt6CZpSZEbZkhRg7wsYEE130_provenance.